Albion Investors
Albion Alliance is a private investment firm based in New York, established in 1995. It specializes in managing investments in private equity and debt, focusing primarily on lower middle-market companies. The firm targets micro-cap deals, mezzanine capital, and growth equity financing, with investments typically ranging from $5 million to $30 million in debt and $3 million to $15 million in equity. Albion seeks to engage in leveraged buyouts, recapitalizations, and distressed investments, concentrating on sectors such as value-added distribution, specialty manufacturing, business services, consumer goods, and media. The firm prefers to take lead positions in transactions involving companies with enterprise values between $2 million and $1 billion and EBITDA greater than $4 million. Albion's investment strategy includes both majority and minority stakes, and its principals invest their own capital in lead transactions. The firm also has the capability to arrange mezzanine financing up to $75 million and operates primarily in the Mid-Atlantic, Northeast, and Southeast regions of the United States, as well as Canada and Europe.
Helveta Ltd develops technology products for the timber and food sectors. It offers The CI World platform, an interactive cartography application that provides auditable traceability, asset tracking, resource and forest use mapping, and chain of custody control for extended supply chains; and allows monitoring logging activities, and to export data points and associated icons to GIS products enabling the online sharing of maps among communities over the Web. The company serves growers, farm managers, agronomists, and buyers. Helveta Ltd was incorporated in 2004 and is based in Oxford, the United Kingdom with operations in Nigeria, the Central African Republic, the Republic of Congo, and Cameroon.
Xceleron, founded in 1997 in York, UK, and now based in Germantown, Maryland, specializes in bioanalytical accelerator mass spectrometry (AMS) services to enhance drug development. The company pioneered techniques for human microdosing and microtracing, focusing on the pharmacokinetics and metabolism of developmental drugs during early clinical trial phases. Xceleron's services include micro-dosing, preclinical evaluation, intravenous pharmacokinetics, metabolite profiling, and mass balance investigations in humans. Their expertise is particularly valuable given the complexity of modern small molecules, which often exhibit low solubility and lengthy half-lives, necessitating early pharmacokinetic characterization to improve the cost-effectiveness of clinical development. Through a commitment to integrity and collaboration, Xceleron aims to accelerate the delivery of life-changing products to the market.
Provider of propane gas utilities intended for residential, commercial and industrial users. The company provides propane energy services, thereby enabling its clients to be provided with quality services at a competitive price.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.